Nadja Klafke1, Jaklin A Eliott2, Ian N Olver3, Gary A Wittert4. 1. School of Psychology, The University of Adelaide, Adelaide, South Australia, Australia. Electronic address: nadja.klafke@adelaide.edu.au. 2. Discipline of General Practice, School of Population Health, The University of Adelaide, Adelaide, South Australia, Australia. 3. Cancer Council Australia, Sydney, New South Wales, Australia; Discipline and School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia. 4. Freemasons Foundation Centre for Men's Health Research, Discipline of Medicine, University of Adelaide, Adelaide, South Australia, Australia.
Abstract
PURPOSE: To explore how men's Significant Others (SOs), including family members and close friends, contribute to the uptake and maintenance of specific CAM therapies. METHODS: This study was the second, qualitative phase of a mixed-methods project investigating the use of CAM in an Australian male cancer population. Male participants were purposefully selected from a pool of 403 patients who answered a survey in the first quantitative phase (94% response rate and 86% consent rate for follow-up interview). Then semi-structured interviews among 26 men with a variety of cancers and 24 SOs were conducted. All 43 interviews were recorded, transcribed, and analysed thematically. RESULTS: Men used CAM/Natural products to cope with physical concerns, and this was actively supported by men's SOs who contributed to the uptake and maintenance of these CAMs. The shared CAM preparation and consumption functioned to strengthen the bond between men and their SOs, and also helped men's SOs to cope with uncertainty and regain control. In contrast, men practiced CAM/Mind-body medicine to receive emotional benefits, and only rarely shared this practice with their SOs, indicating a need for coping with emotions in a private way. CONCLUSIONS: Men's CAM use is a multifaceted process that can be better understood by considering CAM categories separately. CAM/Natural products help men to cope with physical concerns, while CAM/Mind-body medicine assist men to cope with their emotions in a private way. Oncology professionals can use this information to better promote and implement integrative cancer care services.
PURPOSE: To explore how men's Significant Others (SOs), including family members and close friends, contribute to the uptake and maintenance of specific CAM therapies. METHODS: This study was the second, qualitative phase of a mixed-methods project investigating the use of CAM in an Australian male cancer population. Male participants were purposefully selected from a pool of 403 patients who answered a survey in the first quantitative phase (94% response rate and 86% consent rate for follow-up interview). Then semi-structured interviews among 26 men with a variety of cancers and 24 SOs were conducted. All 43 interviews were recorded, transcribed, and analysed thematically. RESULTS:Men used CAM/Natural products to cope with physical concerns, and this was actively supported by men's SOs who contributed to the uptake and maintenance of these CAMs. The shared CAM preparation and consumption functioned to strengthen the bond between men and their SOs, and also helped men's SOs to cope with uncertainty and regain control. In contrast, men practiced CAM/Mind-body medicine to receive emotional benefits, and only rarely shared this practice with their SOs, indicating a need for coping with emotions in a private way. CONCLUSIONS:Men's CAM use is a multifaceted process that can be better understood by considering CAM categories separately. CAM/Natural products help men to cope with physical concerns, while CAM/Mind-body medicine assist men to cope with their emotions in a private way. Oncology professionals can use this information to better promote and implement integrative cancer care services.
Keywords:
Caregiver; Complementary and Alternative Medicine (CAM); Family; Gendered health issues; Integrative cancer care; Men; Posttraumatic growth; Psycho-social care
Authors: Nadja Klafke; Cornelia Mahler; Cornelia von Hagens; Gisela Blaser; Martina Bentner; Stefanie Joos Journal: Support Care Cancer Date: 2015-12-02 Impact factor: 3.359